{"wdi-IC.FRM.RSDV.ZS": {"data": {"2010": {"ATG": 22.9, "BHS": 28.4, "BRB": 33.7, "BLZ": 4.8, "DMA": 12.1, "DOM": 27.3, "GRD": 27.4, "GUY": 46.1, "JAM": 20.4, "KNA": 30.2, "LCA": 9.9, "VCT": 30.1, "SUR": 4.3, "TTO": 12.4}, "2015": {"PNG": 21.5, "SLB": 20.0, "TLS": 22.2}, "2016": {"DOM": 5.7}, "2018": {"SUR": 19.7}, "recentValue": {"ATG": 22.9, "BHS": 28.4, "BRB": 33.7, "BLZ": 4.8, "DMA": 12.1, "DOM": 5.7, "GRD": 27.4, "GUY": 46.1, "JAM": 20.4, "PNG": 21.5, "SLB": 20.0, "KNA": 30.2, "VCT": 30.1, "LCA": 9.9, "SUR": 19.7, "TLS": 22.2, "TTO": 12.4}, "recentYear": {"ATG": "2010", "BHS": "2010", "BRB": "2010", "BLZ": "2010", "DMA": "2010", "DOM": "2016", "GRD": "2010", "GUY": "2010", "JAM": "2010", "PNG": "2015", "SLB": "2015", "KNA": "2010", "VCT": "2010", "LCA": "2010", "SUR": "2018", "TLS": "2015", "TTO": "2010"}}, "def": "Percent of firms that spend on research and development.", "name": "Firms that spend on R&D", "source": "World Bank, Enterprise Surveys (http://www.enterprisesurveys.org/).", "dataset": "World Bank, Enterprise Surveys (http://www.enterprisesurveys.org/).", "category": "Private Sector & Trade", "subcategory": "Business environment", "link": "https://data.worldbank.org/indicator/wdi-IC.FRM.RSDV.ZS", "dim": "none", "priority": "1.0", "units": "% of firms"}, "confidenceIntervals": {"2010": {"BHS": 7.1, "GUY": 4.61, "LCA": 9.9}, "2015": {"PNG": 3.0714285714285716}, "2016": {}, "2018": {"SUR": 1.97}, "recentValue": {"BRB": 33.7, "GRD": 2.7399999999999998, "JAM": 2.04, "SLB": 5.0}}, "featureImportances": {"indicators": {"wdi2-NV.IND.TOTL.KD.ZG": 0.101, "ihme-leprosy": 0.442, "wdi-IQ.CPA.MACR.XQ": 0.922, "ihme-trachoma": 0.534, "wdi-IQ.CPA.FINQ.XQ": 0.419, "wdi2-SL.EMP.TOTL.SP.ZS": 0.048, "ihme-other-pneumoconiosis": 0.315, "wdi2-NY.ADJ.AEDU.CD": 0.715, "wdi2-SP.URB.TOTL.IN.ZS": 0.666, "wdi2-SH.STA.OWGH.ME.ZS": 0.004}, "categories": {"Musculoskeletal disorders": 0.42, "Other non-communicable diseases": 0.89, "Pneumoconiosis": 0.157, "Demography": 0.734}}}